Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what consideration she has given to a centralised approach to Information Governance to reduce variation in digital communication methods and practices between NHS Trusts.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

There is an NHS Information Governance portal, which provides a single, consistent national source of information governance guidance for health and social care providers. NHS England has a working group to check and challenge the guidance, which includes representatives of the Information Commissioner's Office and the Office of the National Data Guardian.

It is for each trust, as controller, to decide how they communicate with their patients. We have produced national guidance on texting, emailing, and messaging patient and service users to support organisations with information governance requirements. This guidance is available at the following link:

https://digital.nhs.uk/data-and-information/information-governance/guidance/texting-emailing-and-messaging-patients-and-service-users/guidance-for-patients-and-service-users

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of multiple sclerosis and other progressive neurological conditions in England.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his department is taking to increase capacity within NHS neurology services.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether her department will consider the establishment of national leadership to support alignment between NHS data initiatives in multiple sclerosis and neurology.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department plans to take to increase the prioritisation of multiple sclerosis and other progressive neurological conditions in national health policy.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the number of consultant neurologists and specialist multiple sclerosis nurses in England.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to address variations in access to care for people with multiple sclerosis and other progressive neurological conditions.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of support available to people with multiple sclerosis and other progressive neurological conditions.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential merits of using pre appointment patient questionnaires via the NHS App for people with multiple sclerosis and other progressive neurological conditions, to better understand patient need and ensure they are seen by the right service, at the right time.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to consider specialised neurology services as part of NHS England’s review of commissioning, including services for patients living with multiple sclerosis.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure comprehensive support is provided to people with multiple sclerosis at the time of diagnosis.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will commit to maintaining support for the recently established Neuro Forum over the course of this Parliament.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of provision of patient education and support at the time of diagnosis for people with multiple sclerosis; and what improvements can be made.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how specialised commissioning expertise will be maintained following the merger of NHS England and her Department, including for the commissioning of services for people with multiple sclerosis.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what consideration she has given to ensuring that the implementation of the 10 Year Health Plan leads to improved care and outcomes for people affected by progressive neurological conditions, including multiple sclerosis.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the adequacy of data collection regarding service performance and patient outcomes in multiple sclerosis and neurology.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what resources are available to support care coordination, across geographies and disciplines, for multiple sclerosis and other progressive neurological conditions.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve data collection in relation to care provided to people with multiple sclerosis and other progressive neurological conditions outside of hospital settings.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what support her Department is providing to Integrated Care Systems to ensure people with multiple sclerosis receive the best possible care.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions.

Through NHS England’s Neurology Transformation Programme, a new model of integrated care has also been developed to support integrated care boards (ICBs) to deliver the right service, at the right time for all neurology patients. This focuses on providing access equitably across the country, with care as close to home as possible, and early intervention to prevent illness and deterioration in patients with long-term neurological conditions, including MS. A toolkit was developed to support ICBs to understand and implement this new model, which includes components on delivering acute neurology services, improving health equity in neurology, and improving community neurology services.

NHS England has published an updated service specification for specialised neurology services, including MS, which sets out clear expectations for proactive, coordinated care to reduce the risk of avoidable complications and emphasises early identification of clinical risks, personalised care planning, and timely access to multidisciplinary support, including specialist nurses, therapists, and community services.

In addition, the GIRFT Programme for Neurology, the RightCare Progressive Neurological Conditions Toolkit, and the model of integrated neurology care developed through the Neurology Transformation Programme support greater consistency, coordination, and sharing of best practice across local systems and geographical areas. NHS England has developed national neurology dashboards, including an MS data dashboard and an interactive adult neurology dashboard, to support systems in monitoring service delivery, benchmarking performance, and understanding the quality of local neurology services.

The National Institute for Health and Care Excellence (NICE) has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically- and cost‑effective treatments based on the best available evidence. ICBs are expected to have regard to NICE guidance to ensure patients can access high‑quality care and treatment. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.

The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.

Finally, a UK-wide neuro forum has been convened, bringing together the governments, health services, and Neurological Alliances of all four UK nations. The forum will share learnings across the UK, and discuss important neurology services transformation and workforce challenges, as well as best practice examples and potential solutions.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve brain tumour research.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

I refer the Hon Member to the answer provided on 25 June in response to Question 9944.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what support is available for people living with fibromyalgia.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

Integrated care boards are responsible for commissioning services to meet the needs of their local populations, including services for people with fibromyalgia and children with Tourette syndrome.

Support for people with fibromyalgia may be provided through primary care, pain management, rheumatology, physiotherapy, and psychological therapies, according to individual clinical need. The National Institute for Health and Care Excellence (NICE) has published guidance on the assessment of chronic pain and the management of chronic primary pain, which healthcare professionals and commissioners are expected to take fully into account.

For children with Tourette syndrome, care may be provided by local paediatric, neurological, neurodevelopmental, or child and adolescent mental health services. Where the condition has a significant impact on daily life, NICE guidance recommends referral to an appropriate specialist service for assessment and treatment.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether there are specialist services for children diagnosed with Tourette syndrome.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

Integrated care boards are responsible for commissioning services to meet the needs of their local populations, including services for people with fibromyalgia and children with Tourette syndrome.

Support for people with fibromyalgia may be provided through primary care, pain management, rheumatology, physiotherapy, and psychological therapies, according to individual clinical need. The National Institute for Health and Care Excellence (NICE) has published guidance on the assessment of chronic pain and the management of chronic primary pain, which healthcare professionals and commissioners are expected to take fully into account.

For children with Tourette syndrome, care may be provided by local paediatric, neurological, neurodevelopmental, or child and adolescent mental health services. Where the condition has a significant impact on daily life, NICE guidance recommends referral to an appropriate specialist service for assessment and treatment.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, in what way the NHS is supporting patients with hidradenitis suppurativa.

Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)

The National Health Service supports patients with hidradenitis suppurativa (HS) through a multi-layered approach that combines community-based primary care, specialist dermatological treatments, and targeted mental health integration. Because HS is a painful, chronic, inflammatory skin condition, the NHS focuses on reducing the frequency of flare-ups, managing wounds, and addressing severe impact on quality of life.

The Getting it Right First Time dermatology programme supports patients with HS by working with NHS trusts to improve patient pathways, reduce unnecessary appointments, share best practice, and make better use of technology. This work is intended to improve access, reduce waiting times, and ensure specialist dermatology capacity is available for patients with complex conditions, including HS.

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment she has made of the implications for her policies of reports that veterinary practices in Northern Ireland are experiencing difficulties obtaining diagnostic equipment and replacement components.

Answered by Stephen Morgan - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

This Government has not received reports of any issues with the supply of diagnostic equipment or replacement components to veterinary practices in Northern Ireland.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps are being taken to improve awareness and diagnosis of polycystic ovary syndrome.

Answered by Diana Johnson - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer given on 1 July in response to Question 10605.

Human rights in Bahrain

Love Newcastle-under-Lyme Business Awards 2026

Planned job losses at Greggs plc

Defibrillators in police vehicles

Post-16 education

ClubSport Stirling

Work of Sands and Baby Loss Awareness Week

Higher Education In Scotland

Fortune Works' shortlisting in the Nature of Scotland Awards

Macmillan Coffee Mornings in Chesterfield

30 years of Maggie’s in Glasgow

Local authority reimbursement for costs associated to families with no recourse to public funds

Harley Russell and Noah Reed fundraising for Berkshire Women's Aid

Glasgow Warriors' Fundraising for Glasgow Children’s Hospital Charity

Data on children awaiting specialist SEND placements

Turnbull High School work with Refuweegee

Sir George Dowty

Shetland Wool Week 2026

Ukrainian Day of Defenders

King Alfred Pilgrimage route extension

Frome Carnival

Radio Brockley 60th anniversary

100th Birthday of Christina McGrath of Holywood

Cool Planet Technologies carbon capture plant

Diana Perry and the Ectodermal Dysplasia Society

Wrexham's Bid for City of Culture 2029

Max Langlands and the National Fish and Chip Awards

Shetland apprentices and BBC Scotland

European Tram Driver Championship

River Lavant

Administration of PAPYRUS

55th anniversary of Drumcree Women’s Institute

90th anniversary of the Jarrow Crusade

19th International Day of Democracy

Scotmid Co-operative Support for DEC Venezuela Earthquake Appeal

GSCE attainment gap and dyslexia

Support for off-grid homes

80th anniversary of the Ulster Regiment of the Church Lads’ and Church Girls’ Brigade

Fundraising at Morrisons, Goose Street, Newcastle-under-Lyme

Commemorating the passing of British-Nepali climber Nirmal "Nims" Purja MBE

20 Years of Guildford Shakespeare Company

Dan Hughes Heart Screening Event

The Northumberland Arms

Primary 7 at Dalry Primary School

Friends of the Pentland Hills

Fur Belongs to Animals campaign

Carol-Ann Innes, Girlguiding and the Second Faifley Brownies

150th anniversary of Stourbridge Football Club

Humanitarian situation in Russian-occupied Oleshky

Contribution of parish and town councils to local democracy

Charter for Community Rights

ivvi Notes

Afghan Musicians and Film Collaboration

International panel on inequality and the UK's 2027 G20 presidency

Cancer treatment in rural areas

50 years of St Lucy’s Roman Catholic Church, Cumbernauld

20 years of LINKES

Baby Loss Awareness Week and the work of Held In Our Hearts

Challenge Poverty Week 2026

90th anniversary of Vent-Axia in Crawley

40th Anniversary of Lothian Regional Transport plc

Taxation of bank windfall profits

300th anniversary of First Antrim Presbyterian Church

Orkney Nature Festival Photography Competition

Donna Cuthbertson and the BBC Scotland Make A Difference Awards

First child born on North Ronaldsay in more than 30 years

Orkney and Shetland girls’ participation in sport

British Wool Month and Baavet, Porthmadog

Devizes Town Crier, winner of National Town Crier Championship

Lesley Councill's service to Priorswood Community

Jammu and Kashmir Accession Day

Retaining the Triple Lock on pensions

Baby Loss Awareness Week (No. 2)

Lauri Siegel at the World Championships

Shetland hospitality businesses at Highlands and Islands Thistle Awards

Catriona Macdonald doctorate from Newcastle University

Health All Round

Cumberland and Westmorland Wrestling

10th Anniversary of The Welcoming's Friendship Programme

Karl Thompson and the Sandals Foundation Island Challenge

Tackling stigma

Contribution of CLASP in Wokingham

University of St Andrews named top university

Eco Skills Learning Centre

10th anniversary of The Venue Community Centre, Stanley

Commemorating victims of the Arandora Star tragedy of 1940

Hospitality VAT reduction and the VAT Is The Problem campaign

Robert Macklin nominated for Glasgow Times Sporting Champion of the Year

Glasgow Wood 20th anniversary

Dam Mire Wood Project

People's Emergency Briefing screening in Edinburgh South West

Stephanie Gardiner

Barrow Raiders and the 2026 Rugby Football League club grading

Jack Ellerby

Nexus Games Torquay